Cargando…

Stroke Incidence and Death in Atrial Fibrillation Patients Newly Treated with Direct Oral Anticoagulants

PURPOSE: The objectives were to analyse the determinants of stroke incidence and mortality as a competing event in AF patients newly treated with DOAC and to assess the impact of non-adherence to DOAC treatment. METHODS: It is a population-based retrospective cohort study using the French national h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gabet, Amélie, Chatignoux, Edouard, Grave, Clémence, Vallée, Alexandre, Tuppin, Philippe, Béjot, Yannick, Olié, Valérie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903960/ https://www.ncbi.nlm.nih.gov/pubmed/33642879 http://dx.doi.org/10.2147/CLEP.S290707

Ejemplares similares

Patients Hospitalized for Ischemic Stroke and Intracerebral Hemorrhage in France: Time Trends (2008–2019), In-Hospital Outcomes, Age and Sex Differences
por: Olié, Valérie, et al.
Publicado: (2022)

Atrial Fibrillation in Spontaneous Intracerebral Hemorrhage, Dijon Stroke Registry (2006–2017)
por: Gabet, Amélie, et al.
Publicado: (2021)

Comparison of Stroke Recurrence, Cardiovascular Events, and Death Among Patients With Pregnancy-Associated vs Non–Pregnancy-Associated Stroke
por: Béjot, Yannick, et al.
Publicado: (2023)

Changes in the epidemiology of patients hospitalized in France with deep venous thrombosis and pulmonary embolism during the COVID-19 pandemic
por: Gabet, Amélie, et al.
Publicado: (2021)

Fourteen-Year Temporal Trends in Patients Hospitalized for Mitral Regurgitation: The Increasing Burden of Mitral Valve Prolapse in Men
por: Grave, Clémence, et al.
Publicado: (2022)

Epidemiological Features of Aortic Stenosis in a French Nationwide Study: 10‐Year Trends and New Challenges
por: Grave, Clémence, et al.
Publicado: (2020)

Care management and 90-day post discharge mortality in patients hospitalized for myocardial infarction and COVID-19: A French nationwide observational study
por: Grave, Clémence, et al.
Publicado: (2022)

Myocardial infarction throughout 1 year of the COVID-19 pandemic: French nationwide study of hospitalization rates, prognosis and 90-day mortality rates()
por: Grave, Clémence, et al.
Publicado: (2021)

Nationwide Initiation of Cardiovascular Risk Treatments During the COVID-19 Pandemic in France: Women on a Slippery Slope?
por: Gabet, Amélie, et al.
Publicado: (2022)

The 2015 and 2016 terrorist attacks in France: was there a short-term impact on hospitalizations for cardiovascular disease?
por: Chatignoux, Edouard, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for venous thromboembolism and pulmonary embolism in France
por: Gabet, A., et al.
Publicado: (2022)

Initiation d'un traitement du risque cardiovasculaire au cours de la pandémie de COVID-19 en France
por: Gabet, A., et al.
Publicado: (2022)

Relationship between Nutrition and Alcohol Consumption with Blood Pressure: The ESTEBAN Survey
por: Vallée, Alexandre, et al.
Publicado: (2019)

Underuse of lifestyle recommendations in hypertension management in France: The Esteban study
por: Vay‐Demouy, Juliette, et al.
Publicado: (2022)

Variations of cardiovascular procedures (diagnostic and therapeutic) in France during COVID-19 epidemic (2020–21): An observational nationwide study
por: Tuppin, P., et al.
Publicado: (2023)

Time Trends in Atrial Fibrillation-Associated Stroke and Premorbid Anticoagulation: Population-Based Study and Systematic Review
por: Yiin, Gabriel S.C., et al.
Publicado: (2019)

Les infarctus du myocarde pendant un an de pandémie de COVID-19 - Étude nationale française des taux d'hospitalisation, du pronostic et de la mortalité à 90 jours
por: Grave, C., et al.
Publicado: (2022)

One year of Covid-19: French nationwide study of hospitalisation, 90-day readmission and mortality rates from myocardial infarction
por: Grave, C., et al.
Publicado: (2022)

Care management and 90-day mortality in patients hospitalized for myocardial infarction and COVID-19 in France
por: Grave, C., et al.
Publicado: (2022)

Hypertension prevalence, awareness, treatment and control in 2019 in the adult population of Mayotte
por: Calas, Lucinda, et al.
Publicado: (2022)

Prevalence and management of hypercholesterolemia in France, the Esteban observational study
por: Blacher, Jacques, et al.
Publicado: (2020)

Need for improvement of cardiovascular health: a clustering method to identify cardiovascular health profiles.: From epidemiological surveillance to identification of targeted audiences for prevention campaigns
por: Soyer, Jessica, et al.
Publicado: (2023)

Nationwide initiation of cardiovascular risk treatments during the COVID-19 pandemic in France: Women on a slippery slope?
por: Gabet, A., et al.
Publicado: (2023)

Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study
por: Lailler, Grégory, et al.
Publicado: (2023)

Anticoagulant prescribing for atrial fibrillation and risk of incident dementia
por: Cadogan, Sharon Louise, et al.
Publicado: (2021)

Estimating the Future Burden of Myocardial Infarction in France Until 2035: An Illness-Death Model-Based Approach
por: Kuhn, Johann, et al.
Publicado: (2022)

Prevalence of hypertensive disorders during pregnancy in France (2010‐2018): The Nationwide CONCEPTION Study
por: Olié, Valérie, et al.
Publicado: (2021)

Adverse Maternal and Infant Outcomes in Women With Chronic Hypertension in France (2010–2018): The Nationwide CONCEPTION Study
por: Lailler, Grégory, et al.
Publicado: (2023)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Trajectories of Oral Anticoagulation Adherence Among Medicare Beneficiaries Newly Diagnosed With Atrial Fibrillation
por: Hernandez, Inmaculada, et al.
Publicado: (2019)

Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation
por: Fox, Keith A. A., et al.
Publicado: (2020)

Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation
por: Yong, Celina M., et al.
Publicado: (2020)

Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020
por: Ko, Darae, et al.
Publicado: (2022)

Stroke incidence and anticoagulation treatment in patients with pacemaker-detected silent atrial fibrillation
por: Sandgren, Emma, et al.
Publicado: (2018)

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation—The EWA study
por: Jaakkola, Samuli, et al.
Publicado: (2017)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
por: Kim, Kyu, et al.
Publicado: (2018)

Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation
por: Charlton, Alethea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ig7vtcv0gcc70kh3o6jt4b92kj